Why do Indian health authorities keep quiet on pharma firms’ failings? – Business Standard
0
Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty – or if the USFDA is to be believed, falsified – data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent onlookers. The Indian drug industry is estimated at around Rs 80,000 crore, and is a powerhouse of generic medicines (sometimes referred to as copycat medicines).
Read more – Business Standard